Australia Digital Therapeutics Market Size & Outlook
Australia digital therapeutics market, 2018-2030 (US$M)
Related Markets
Australia digital therapeutics market highlights
- The Australia digital therapeutics market generated a revenue of USD 18.7 million in 2023 and is expected to reach USD 149.6 million by 2030.
- The Australia market is expected to grow at a CAGR of 34.6% from 2024 to 2030.
- In terms of segment, diabetes was the largest revenue generating application in 2023.
- Diabetes is the most lucrative application segment registering the fastest growth during the forecast period.
Digital therapeutics market data book summary
| Market revenue in 2023 | USD 18.7 million |
| Market revenue in 2030 | USD 149.6 million |
| Growth rate | 34.6% (CAGR from 2023 to 2030) |
| Largest segment | Diabetes |
| Fastest growing segment | Diabetes |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases |
| Key market players worldwide | Omega Healthcare Investors Inc, Teladoc Health Inc, ResMed Inc, Fitbit, Mango Health, Akili Inc Ordinary Shares, Hygeia Healthcare Holdings Co Ltd Ordinary Shares, DarioHealth Corp, BioGaia AB Class B |
Other key industry trends
- In terms of revenue, Australia accounted for 0.3% of the global digital therapeutics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China digital therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 149.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Therapeutics Market Scope
Digital Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia digital therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital therapeutics market will help companies and investors design strategic landscapes.
Diabetes was the largest segment with a revenue share of 31.02% in 2023. Horizon Databook has segmented the Australia digital therapeutics market based on diabetes, obesity, cvd, respiratory diseases, smoking cessation, cns diseases covering the revenue growth of each sub-segment from 2018 to 2030.
- Australia Digital Therapeutics Application Outlook (Revenue, USD Million, 2018-2030)
- Diabetes
- Obesity
- CVD
- Respiratory Diseases
- Smoking Cessation
- CNS Diseases
- Others
- Australia Digital Therapeutics End Use Outlook (Revenue, USD Million, 2018-2030)
- Patients
- Providers
- Payers
- Employers
- Others
Reasons to subscribe to Australia digital therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia digital therapeutics market databook
-
Our clientele includes a mix of digital therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia digital therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Australia digital therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia digital therapeutics market size, by application, 2018-2030 (US$M)
Australia Digital Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
